Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Cell division cycle 25A (CDC25A) mRNA 3' untranslated region (UTR) is a key regulatory sequence located at the 3' end of the CDC25A messenger RNA. CDC25A itself is a dual-specificity phosphatase that plays a pivotal role in the cell cycle by activating cyclin-dependent kinases (CDKs), specifically triggering the G1/S and G2/M transitions (UniProt: P30304). The 3' UTR serves as a hub for post-transcriptional control, containing binding sites for various microRNAs (miRNAs) such as miR-21, miR-34a, and miR-449a, which regulate mRNA stability and translation (PubMed: 17574024, 19448674). In many human cancers, CDC25A is frequently overexpressed, often correlating with poor prognosis and aggressive tumor behavior, making its regulatory elements attractive therapeutic targets (PubMed: 15933744). Therapeutic strategies targeting the CDC25A mRNA 3' UTR include the use of miRNA mimics or antisense oligonucleotides (ASOs) to induce mRNA degradation or block translation, thereby inhibiting cell proliferation. While promising, these approaches face challenges regarding delivery efficiency and the potential for off-target effects on other transcripts sharing similar regulatory motifs.
RNA interference (RNAi) or antisense-mediated degradation and translational repression of the CDC25A transcript by binding to specific regulatory motifs within the 3' UTR.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell division cycle 25A mRNA 3' untranslated region (CDC25A mRNA 3' UTR).